TULP1 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role of TULP1

TULP1 is a cytoplasmic, membrane-associated protein essential for photoreceptor synaptic organization, endocytosis at periactive zones, and protein transport to photoreceptor outer segments . Mutations in the TULP1 gene cause severe retinal degenerations such as retinitis pigmentosa (RP14) and Leber congenital amaurosis (LCA15) .

Development and Specificity of TULP1 Antibodies

Two primary antibodies have been characterized for TULP1 detection:

  • Polyclonal antibody (T1N1): Targets the 18 N-terminal amino acids of human TULP1, conserved across species (human, mouse, bovine) .

  • Monoclonal antibody (5G2-4): Binds an internal peptide (amino acids 50–59: PTGSKPRRPG) of bovine TULP1 .

Validation Data:

Antibody TypeTarget RegionSpecificity ConfirmationMolecular Weight Detection
T1N1 (Polyclonal)N-terminalWestern blot, Tulp1⁻/⁻ controls~60 kDa band in wild-type retina, absent in knock-out
5G2-4 (Monoclonal)Internal peptideImmunocytochemistry, knock-out validation~60 kDa band in wild-type retina

Synaptic and Endocytic Functions

  • TULP1 antibodies localized TULP1 to photoreceptor periactive zones, where it colocalizes with endocytic proteins (e.g., clathrin) and interacts with synaptic ribbon protein RIBEYE .

  • Knock-out studies showed TULP1 deficiency disrupts synaptic ribbon integrity and reduces endocytic vesicle retrieval .

Disease Mechanisms

  • TULP1 mutations trigger endoplasmic reticulum (ER) stress, contributing to photoreceptor apoptosis .

  • Antibodies confirmed mislocalization of mutant TULP1 in cellular models of RP and LCA .

Therapeutic Applications

In Tulp1⁻/⁻ mice, AAV-mediated Tulp1 gene therapy utilized TULP1 antibodies to validate protein expression post-treatment:

  • Subretinal AAV2/5 delivery restored TULP1 levels to 80–100% of wild-type by p20, but failed to rescue outer nuclear layer (ONL) thinning by p90 .

  • Immunohistochemistry confirmed TULP1 expression in transduced photoreceptors .

Clinical Correlations

A 2025 study identified anti-TULP1 autoantibodies in systemic and ocular pathologies :

Cancer-Associated Autoantibodies

Cancer TypeTotal CasesTULP1 PositivityPositivity Ratep Value
Breast cancer903640%0.015
Melanoma10355%0.173
Lung cancer591119%0.748
  • Anti-TULP1 autoantibodies were significantly elevated in breast cancer patients with vision loss compared to other cohorts .

Ocular Diseases

  • TULP1 antibodies detected protein truncations in retinitis pigmentosa (RP) patients, aiding molecular diagnosis .

Functional Insights from Antibody-Based Assays

  • Western blotting: Confirmed TULP1’s ~60 kDa size and absence in knock-out models .

  • Immunocytochemistry: Visualized TULP1’s periactive zone localization and interaction with RIBEYE in photoreceptor synapses .

  • ELISA: Quantified autoantibody titers in cancer and retinal disease patients .

Limitations and Future Directions

  • Therapeutic challenges: TULP1 supplementation in Tulp1⁻/⁻ mice improved protein levels but not ONL survival, suggesting additional pathways are involved .

  • Diagnostic potential: Anti-TULP1 autoantibodies may serve as biomarkers for breast cancer-associated retinopathy, warranting larger cohort studies .

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid repeated freeze-thaw cycles.
Lead Time
Typically, we can ship your order within 1-3 business days of receipt. Delivery times may vary depending on the purchasing method and location. For specific delivery information, please consult your local distributors.
Synonyms
RP14 antibody; Tubby like protein 1 antibody; Tubby related protein 1 (Tubby like protein 1) antibody; Tubby related protein 1 antibody; Tubby-like protein 1 antibody; Tubby-related protein 1 antibody; TUBL1 antibody; TULP 1 antibody; Tulp1 antibody; TULP1_HUMAN antibody
Target Names
TULP1
Uniprot No.

Target Background

Function
TULP1 plays a crucial role in photoreceptor development, function, and survival. It is essential for the normal formation of photoreceptor synapses. TULP1 interacts with cytoskeletal proteins and may facilitate protein transport within photoreceptor cells. It binds to various lipids, including phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4,5-bisphosphate, phosphatidylserine, and phosphatidic acid (in vitro). TULP1 contributes to the stimulation of phagocytosis of apoptotic retinal pigment epithelium (RPE) cells and macrophages.
Gene References Into Functions
  • Pathogenic mutations in TULP1 are responsible for the retinitis pigmentosa phenotype in seven familial cases. Notably, a common ancestral mutation is responsible for the disease phenotype in four of these families. PMID: 27440997
  • Photoreceptor degeneration can be caused by missense mutations in TULP1, which trigger an unfolded protein response within the endoplasmic reticulum. PMID: 26987071
  • Exome sequencing has proven valuable in identifying disease genes, particularly in cases of Leber congenital amaurosis, demonstrating its effectiveness over traditional methods. PMID: 24547928
  • Research suggests that mutant tubby like protein 1 (TULP1) proteins are misfolded and accumulate within the endoplasmic reticulum (ER). This accumulation leads to the induction of the unfolded protein response (UPR) stress response complex. PMID: 26427415
  • The TULP1 allele p.Gln301* is a founder mutation prevalent on the Arabian Peninsula. In its homozygous state, it is associated with a recognizable congenital recessive rod-cone dystrophy phenotype. PMID: 25342276
  • Retinal degeneration caused by TULP1 mutations results in a small central island of residual foveal cones at early ages. These cones exhibit reduced sensitivity compared to what is expected based solely on their residual structure. PMID: 25074776
  • Maternal uniparental isodisomy of chromosome 6 has been linked to a mutation in the TULP1 gene as a novel cause of cone dysfunction. PMID: 23499059
  • The single nucleotide polymorphisms rs4374383 and rs9380516 have been associated with the functionally related genes MERTK and TULP1. These genes encode factors involved in the phagocytosis of apoptotic cells by macrophages. PMID: 22841784
  • One recurrent (c.1138A>G; p.Thr380Ala) and one novel (c.1445G>A; p.Arg482Gln) mutations in TULP1 have been identified in Pakistani families with early-onset retinitis pigmentosa. PMID: 22665969
  • Homozygous autosomal recessive retinitis pigmentosa-causing mutations have been found in three Indian families. These mutations include a missense mutation in TULP1. PMID: 22605927
  • Pathogenic mutations in TULP1 are responsible for the autosomal recessive retinitis pigmentosa phenotype in consanguineous Pakistani families. A single ancestral mutation in TULP1 is responsible for the disease phenotype in four out of five families. PMID: 21987678
  • Members of a Surinamese family exhibit a severe early-onset form of autosomal recessive retinitis pigmentosa caused by compound heterozygous mutations in the TULP1 gene. PMID: 17620573
  • Mutations in the TULP1 gene are a rare cause of Leber congenital amaurosis (LCA) or early-onset retinal degeneration (EORD). PMID: 17962469
  • A novel splice-site mutation in TULP1, c.1495+2_1495+3insT, underlies autosomal recessive early-onset RP in a consanguineous Israeli Muslim Arab family. PMID: 18432314
Database Links

HGNC: 12423

OMIM: 600132

KEGG: hsa:7287

STRING: 9606.ENSP00000229771

UniGene: Hs.485208

Involvement In Disease
Retinitis pigmentosa 14 (RP14); Leber congenital amaurosis 15 (LCA15)
Protein Families
TUB family
Subcellular Location
Cytoplasm. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Secreted. Cell junction, synapse.
Tissue Specificity
Retina-specific.

Q&A

What is TULP1 and why is it important in retinal research?

TULP1 is a photoreceptor-specific protein of approximately 61-64 kDa that is primarily expressed in retinal tissue. This protein has critical roles in photoreceptor function, including:

  • Development of photoreceptor synapses

  • Long-term survival of photoreceptor cells

  • Protein transport in photoreceptor cells, particularly through the connecting cilium

  • Stimulation of phagocytosis of apoptotic retinal pigment epithelium cells

TULP1 is particularly significant in retinal research because mutations in the TULP1 gene cause severe, early-onset retinitis pigmentosa (RP14) and Leber congenital amaurosis (LCA15) in humans . Patients typically display congenital nystagmus, night blindness, and severely reduced visual acuity in their first year of life .

What applications are TULP1 antibodies commonly used for in retinal research?

TULP1 antibodies are utilized across multiple experimental applications:

ApplicationCommon DilutionsNotes
Western Blotting (WB)1:500-1:2000Most widely validated application
Immunohistochemistry (IHC)1:20-1:200Often requires antigen retrieval with TE buffer pH 9.0
Immunofluorescence (IF)VariableEffective for localization studies in retinal sections
ELISAVariableLess commonly reported but validated in some antibodies
Immunoprecipitation (IP)Application-specificUsed to identify protein-protein interactions

Researchers should note that optimal dilutions may be sample-dependent and require titration for best results .

What are the criteria for selecting an appropriate TULP1 antibody?

When selecting a TULP1 antibody, consider:

  • Target region specificity: Antibodies are available that target different regions of TULP1 (N-terminus, middle region, C-terminus, tubby domain)

  • Host species: Most commercially available TULP1 antibodies are raised in rabbit

  • Clonality: Both polyclonal and monoclonal options exist, with polyclonals being more common

  • Reactivity: Consider cross-reactivity with species of interest (human, mouse, rat, etc.)

  • Validation: Look for antibodies validated in your specific application and sample type

  • Conjugation: Most TULP1 antibodies are unconjugated, but conjugated versions (e.g., with APC) may be available for specific applications

How can I validate the specificity of a TULP1 antibody?

Validating TULP1 antibody specificity is crucial to ensure reliable experimental results:

  • Western blot validation:

    • Confirm a single band at the expected molecular weight (~60-70 kDa)

    • Compare with positive controls such as retinal tissue lysates

    • Include negative controls such as non-retinal tissues or TULP1 knockout samples

  • Knockout validation:

    • The gold standard for validation is comparing antibody reactivity in wild-type versus TULP1 knockout tissues

    • Antibodies should show a clear band at ~60 kDa in wild-type samples that is absent in knockout samples

  • Multiple antibody approach:

    • Use antibodies targeting different epitopes of TULP1 (e.g., N-terminal and middle region)

    • Consistent results across different antibodies increase confidence in specificity

  • Peptide competition assay:

    • Pre-incubate the antibody with the immunizing peptide prior to application

    • Signal should be diminished or eliminated if the antibody is specific

What are the optimal protocols for using TULP1 antibodies in immunohistochemistry of retinal tissues?

For successful immunohistochemical detection of TULP1 in retinal tissues:

  • Tissue preparation:

    • Fresh-frozen sections (of ~10-12 μm thickness) work well

    • For paraffin-embedded tissues, antigen retrieval is essential, preferably using TE buffer pH 9.0 or citrate buffer pH 6.0

  • Blocking:

    • Block sections with 5% goat serum to reduce background

  • Primary antibody incubation:

    • Dilute antibody appropriately (typically 1:20-1:200 for IHC)

    • Incubate overnight at 4°C for optimal results

  • Detection:

    • For fluorescent detection, use appropriate secondary antibodies (e.g., goat anti-rabbit Alexa Fluor-568)

    • Co-stain with appropriate markers: phalloidin for actin, DAPI for nuclei

    • Examine using fluorescence microscopy with appropriate filters

  • Controls:

    • Include a negative control (omitting primary antibody)

    • When possible, include TULP1 knockout tissue as a negative control

How can TULP1 antibodies be used to investigate the role of TULP1 in the periactive zone of photoreceptor synapses?

TULP1 has been identified as essential for the structural and functional organization of the periactive zone in photoreceptor synapses . To investigate this role:

  • Co-localization studies:

    • Use TULP1 antibodies in combination with antibodies against endocytic proteins

    • Employ high-resolution imaging techniques (confocal microscopy, STED) to determine precise localization

    • Compare localization patterns between wild-type and TULP1 knockout tissues

  • Proximity ligation assays:

    • Investigate protein-protein interactions between TULP1 and other periactive zone proteins

    • This approach can reveal in situ interactions at the nanometer scale

  • Immunoelectron microscopy:

    • For ultrastructural localization of TULP1 relative to synaptic ribbons and endocytic zones

  • Functional analysis:

    • Combine immunofluorescence with endocytic activity assays

    • Correlate TULP1 localization with sites of endocytic vesicle retrieval

    • Compare endocytic activity between wild-type and TULP1-deficient synapses

  • Time-course studies:

    • Monitor changes in TULP1 localization during development or in response to physiological stimuli

What techniques can be used to study TULP1-protein interactions using antibodies?

Several techniques can be employed to study TULP1's interactions with other proteins:

  • Co-immunoprecipitation:

    • Use TULP1 antibodies coupled to protein A beads to precipitate TULP1 and its binding partners from retinal lysates

    • Analyze precipitated proteins by LC-MS/MS to identify novel interaction partners

    • This approach has successfully identified F-actin and RIBEYE as TULP1 binding partners

  • Pulldown assays:

    • Express recombinant TULP1 domains (e.g., tubby domain) and use them as bait

    • Confirm interactions with Western blot using specific antibodies

  • Yeast two-hybrid screening:

    • Use in conjunction with immunoprecipitation to validate interactions

    • RIBEYE was identified as a TULP1 interactor using this approach

  • In vitro binding assays:

    • Use purified proteins to confirm direct interactions

    • Co-sedimentation assays have confirmed TULP1-actin interactions

  • Subcellular fractionation combined with immunoblotting:

    • To determine compartment-specific interactions

    • TULP1 has been found in membrane fractions, suggesting interactions with membrane components

How can we investigate TULP1's role in phospholipid binding using antibodies?

TULP1 has been shown to bind phospholipids, particularly phosphoinositides . To investigate this property:

  • Phospholipid binding assays:

    • Use commercial phospholipid binding kits

    • Compare binding properties of wild-type and mutant TULP1

    • Validate results using immunoblotting with TULP1 antibodies

  • Membrane fractionation studies:

    • Fractionate cells into cytosolic and membrane components

    • Use TULP1 antibodies to detect protein distribution

    • TULP1 associates with the membranous fraction of cells, likely through phospholipid binding

  • Triton X-114 phase separation:

    • Extract cells with Triton X-114 to separate membrane proteins (detergent phase) from soluble proteins (aqueous phase)

    • Analyze phases by immunoblotting with TULP1 antibodies

    • TULP1 primarily partitions to the aqueous phase despite membrane association

  • Liposome binding assays:

    • Prepare liposomes with specific phospholipid compositions

    • Assess TULP1 binding using co-sedimentation or surface plasmon resonance

    • Detect bound TULP1 with specific antibodies

What methodological considerations are important when working with TULP1 antibodies in knockout models?

When using TULP1 antibodies in knockout models (mouse, zebrafish, etc.), consider:

  • Antibody validation:

    • Confirm absence of signal in knockout tissues to verify antibody specificity

    • This is essential before interpreting phenotypic analyses

  • Background signal:

    • Be aware of potential cross-reactivity with other TULP family members (TUB, TULP2, TULP3)

    • Use appropriate blocking to minimize non-specific background

  • Developmental timing:

    • Consider that TULP1 expression may change during development

    • TULP1-knockout animals show early-onset degeneration, so timing of analysis is critical

  • Species considerations:

    • Some species (e.g., zebrafish) have two orthologous genes (tulp1a and tulp1b)

    • Ensure antibodies recognize the appropriate species-specific versions

  • Phenotypic rescue experiments:

    • Use antibodies to confirm re-expression in rescue experiments

    • Particularly important when testing the effects of TULP1 mutations

What are common issues when using TULP1 antibodies and how can they be resolved?

IssuePossible CauseSolution
No signal in Western blotInsufficient proteinIncrease protein loading (TULP1 is specific to retinal tissue)
Improper antibody dilutionOptimize antibody concentration (start with 1:500-1:1000)
Degraded proteinUse fresh samples and add protease inhibitors during extraction
Multiple bandsCross-reactivityTry antibodies targeting different epitopes
Protein degradationUse fresh samples and include protease inhibitors
High background in IHCInsufficient blockingIncrease blocking time/concentration (5% goat serum recommended)
Non-specific bindingOptimize antibody dilution; try 1:20-1:200 range
Autofluorescence (in retinal tissue)Use Sudan Black or commercial autofluorescence quenchers
Inconsistent resultsLot-to-lot antibody variationValidate each new lot against previous results
Sample preparation differencesStandardize fixation and processing protocols

How can TULP1 antibodies be used to understand disease mechanisms in retinitis pigmentosa?

TULP1 antibodies are valuable tools for elucidating the molecular mechanisms of TULP1-associated retinitis pigmentosa:

  • Protein mislocalization studies:

    • Compare TULP1 localization in normal vs. diseased retinas

    • Use antibodies against interacting partners to determine if their localization is also affected

  • Investigating disease mechanisms:

    • Recent research suggests ferroptosis may be involved in TULP1-associated retinal degeneration

    • Use TULP1 antibodies alongside markers for ferroptosis to investigate this connection

  • Genotype-phenotype correlations:

    • Study the effects of different TULP1 mutations on protein expression, localization, and function

    • Use multiple antibodies targeting different regions to detect truncated proteins

  • Developmental studies:

    • Track the expression and localization of TULP1 during retinal development

    • Compare with disease progression in animal models

  • Therapeutic development:

    • Use antibodies to verify correct expression and localization of TULP1 in gene therapy approaches

    • Monitor restoration of interacting protein networks after treatment

How can TULP1 antibodies help investigate its potential role as a transcription factor?

Recent research suggests TULP1 may function as a transcription factor . To investigate this:

  • Nuclear localization studies:

    • Use TULP1 antibodies to detect nuclear localization in photoreceptors

    • In COS7 cells, TULP1 has been observed in both the plasma membrane and nucleus

  • Chromatin immunoprecipitation (ChIP):

    • Use TULP1 antibodies for ChIP experiments to identify DNA binding sites

    • Follow with sequencing (ChIP-seq) for genome-wide analysis

  • Transcriptional assays:

    • Correlate TULP1 binding with expression of target genes

    • Recent work suggests TULP1 can increase transcriptional activity of the tekt2 promoter

  • Protein complex isolation:

    • Immunoprecipitate TULP1 from nuclear fractions to identify associated transcriptional machinery

  • Mutation impact analysis:

    • Compare DNA binding and transcriptional activity of wild-type vs. disease-associated TULP1 mutants

What are the considerations when using TULP1 antibodies across different species models?

Researchers should be aware of important considerations when working with TULP1 antibodies across species:

  • Sequence homology:

    • Zebrafish have two orthologous genes (tulp1a and tulp1b) with approximately 72.45% and 70.94% amino acid identity to human TULP1, respectively

    • Ensure antibodies recognize conserved epitopes

  • Expression patterns:

    • Expression levels may vary across species and cell types

    • In zebrafish, tulp1a shows higher expression than tulp1b in cones, particularly in UV/blue cones

  • Predicted reactivity:

    • Check manufacturer's data on cross-reactivity with your species of interest

    • For example: Cow: 100%, Dog: 100%, Guinea Pig: 91%, Horse: 100%, Human: 100%, Mouse: 85%, Rabbit: 100%, Rat: 91%

  • Antibody validation:

    • Validate each antibody in your specific species model

    • Consider using species-specific positive controls

  • Evolutionary conservation:

    • The tubby domain is highly conserved across species and may be a reliable target for cross-species studies

    • N-terminal regions may show more variability

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.